Patents Assigned to University
  • Publication number: 20190157217
    Abstract: A hybrid composite film, a method of fabricating the hybrid composite film, and an integrated circuit device including the hybrid composite film, the hybrid composite film including a polymer film; and a plurality of organic-inorganic composite particles dispersed in the polymer film, wherein each particle of the plurality of organic-inorganic composite particles includes an inorganic particle and an organic capping layer surrounding the inorganic particle, the organic capping layer having a hydroxyl group-terminated end.
    Type: Application
    Filed: November 21, 2018
    Publication date: May 23, 2019
    Applicant: Industry-Academic Cooperation Foundation, Yonsei University
    Inventors: Seung-won KIM, Jun-won HAN, Yeon-woo KIM, Hye-yun PARK, Cheol-sang YOON, Kangtaek LEE, Hyungjoon JEON, Young-Geon SONG
  • Publication number: 20190153539
    Abstract: The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.
    Type: Application
    Filed: April 20, 2017
    Publication date: May 23, 2019
    Applicants: The United States of America, as represented by the secretary, Dep. of Health and Human Service, British Columbia Cancer Agency Branch, Julius-Maximilians - University of Würzburg, Oregon Health and Science University, Hospital Clinic de Barcelona, Universitat de Barcelona, Oslo University Hospital HF, Board of Regents of the University of Nebraska, The Cleveland Clinic Foundation, Mayo Foundation for Medical Education and Research
    Inventors: Louis M. Staudt, David William Scott, George W. Wright, Andreas Rosenwald, Pau Abrisqueta, Rita Braziel, Elias Campo Guerri, Wing C. Chan, Joseph M. Connors, Jan Delabie, Diego Villa, Kai Fu, Randy D. Gascoyne, Timothy Greiner, Elaine S. Jaffe, Pedro Jares, Anja Mottok, German Ott, Lisa M. Rimsza, Graham Slack, Dennis Weisenburger, Erlend B. Smeland, James Robert Cook
  • Publication number: 20190153664
    Abstract: Described herein is a continuous process fear modifying the properties of polyester and polyester based fibers, such as a poly(butylene terephthalate) (PBT) fiber, comprising subjecting the PBT fiber to alkaline hydrolysis, and optionally further comprising functionalizing the PBT fiber by solution grafting such as fluorination. The alkaline hydrolysis and optionally subsequent functionalization such as fluorination process can be continuous, following the melt blowing/spinning or spun-bonding process. Also described is a nonwoven PBT fiber mat obtained by the surface modification process. Further described is a filtration device comprising the nonwoven PBT fiber mat.
    Type: Application
    Filed: November 30, 2018
    Publication date: May 23, 2019
    Applicants: CUMMINS FILTRATION IP, INC., Regents of the University of Minnesota
    Inventors: Zaifei Wang, Frank S. Bates, Christopher W. Macosko, Kan Wang, William C. Haberkamp, Christopher E. Holm
  • Publication number: 20190153437
    Abstract: This disclosure relates to analyzing the end-to-end sequence and the relative distributions in heterogeneous mixtures of polynucleotides and methods and enabling reagents related thereto.
    Type: Application
    Filed: February 1, 2019
    Publication date: May 23, 2019
    Applicants: Emory University, The Johns Hopkins University
    Inventors: Mark C. Emerick, William S. Agnew
  • Publication number: 20190151183
    Abstract: A coupling device couples a walker to a torso orthosis which is coupled to a person. The coupling device includes an orthosis coupling member coupled to said torso orthosis, a walker coupling member coupled to said walker, and a mechanism coupled to the orthosis coupling member from its first end and to the walker coupling member from its second end. The mechanism constrains said orthosis coupling member to move along a free line. The torso orthosis is worn by the person and said coupling device is coupled to both said walker and said torso orthosis. The person may be walking along a moving direction not parallel with said free line. The mechanism forces said walker and torso orthosis to move along said moving direction and allows said torso orthosis to move freely along said free line when said moving direction is not parallel with said free line.
    Type: Application
    Filed: November 20, 2018
    Publication date: May 23, 2019
    Applicant: The Regents of the University of California
    Inventors: Homayoon Kazerooni, Katherine Marie Fearing, Wayne Yi-wey Tung
  • Publication number: 20190157229
    Abstract: Provided is an electrode like a protruding electrode that is self-standing on a substrate. A conductive paste (202) contains a conductive powder, an alcoholic liquid component, and no adhesives. The conductive powder contains conductive particles having a thickness of 0.05 ?m or more and 0.1 ?m or less and a representative length of 5 ?m or more and 10 ?m or less, the representative length being a maximum diameter in a plane perpendicular to the direction of the thickness. The weight percentage of the alcoholic liquid component relative to the conductive paste is 8% or more and 20% or less.
    Type: Application
    Filed: April 28, 2017
    Publication date: May 23, 2019
    Applicants: Sharp Kabushiki Kaisha, Osaka University
    Inventors: Tomotoshi SATOH, Hiroya SATO, Katsuaki SUGANUMA, Aiji SUETAKE, Shijo NAGAO, Jinting JIU, Seiichiro KIHARA
  • Publication number: 20190153466
    Abstract: Embodiments of the present disclosure pertain to modified plants or seeds that contain a mutated gene. The mutated gene includes, without limitation, a pic30 mutant, a mutant homolog of pic30, and combinations thereof. The modified plant or seed is resistant to at least one herbicide, such as picloram. The modified plant or seed may also be resistant to one or more sources of environmental stress, such as drought, plant pathogenesis, biotic stress, and abiotic stress. Additional embodiments of the present disclosure pertain to methods of controlling the growth of weeds in a field by applying at least one herbicide to the field that includes the aforementioned modified plants or seeds. Additional embodiments of the present disclosure pertain to methods of developing the aforementioned modified plants or seeds by introducing one or more of the aforementioned mutated genes to a plant or seed.
    Type: Application
    Filed: November 20, 2018
    Publication date: May 23, 2019
    Applicant: Texas State University
    Inventors: Nihal Dharmasiri, Sunethra Dharmasiri, Praveen Kumar Kathare
  • Publication number: 20190157508
    Abstract: A device includes a light-emitting diode (LED) integrated with a photodetector on the same semiconductor platform, such that the photocurrent generated by the photodetector can be used to monitor the optical output of the LED, which is located adjacent to the photodetector. The device provides a compact, robust, reliable and low-cost way of monitoring LED emission.
    Type: Application
    Filed: May 17, 2016
    Publication date: May 23, 2019
    Applicant: The University of Hong Kong
    Inventors: Hoi Wai CHOI, Kwai Hei LI, Haitao LU
  • Publication number: 20190153442
    Abstract: Provided herein are methods for the treatment of poly-cystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.
    Type: Application
    Filed: August 25, 2016
    Publication date: May 23, 2019
    Applicants: Regulus Therapeutics Inc., Board of Regents of the University of Texas System
    Inventors: John R. Androsavich, B. Nelson Chau, Vishal D. Patel
  • Publication number: 20190157576
    Abstract: Phosphorescent materials and devices with high device efficiency, stability, and processibility.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 23, 2019
    Applicant: Universal Display Corporation
    Inventors: Raymond Kwong, Bin Ma, Chuanjun Xia, Bert Alleyne, Jason Brooks
  • Publication number: 20190157581
    Abstract: Organic devices comprising an organic semiconducting acceptor motif coupled to a donor motif. Examples include IOTIC-2F, ITOTIC-2F, COTIC-4F, and SiOTIC-4F as acceptor materials. The acceptor materials have narrow bandgap (1.1 eV-1.3 eV), strong near-IR absorption and high solar cell EQE in near infrared (IR) region. The acceptor materials may also be used as the absorbing/light sensitive region in an IR photodetector.
    Type: Application
    Filed: November 2, 2018
    Publication date: May 23, 2019
    Applicant: The Regents of the University of California
    Inventors: Martin Seifrid, Guillermo C. Bazan, Jaewon Lee, Thuc-Quyen Nguyen, Ben Luginbuhl, Seo-Jin Ko
  • Publication number: 20190153482
    Abstract: Lactic acid bacterial cultures, cell populations and articles of manufacture comprising same are disclosed for generating ethanol from lignocellulse.
    Type: Application
    Filed: December 12, 2018
    Publication date: May 23, 2019
    Applicants: The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organiziz, Yeda Research and Development Co. Ltd., Ramot at Tel-Aviv University Ltd.
    Inventors: Itzhak MIZRAHI, Naama SHTERZER, Raphael LAMED, Inna ROZMAN GRINBERG, Edward A. BAYER, Sarah MORAIS, Etai LANDOU
  • Publication number: 20190150822
    Abstract: Methods and systems for diagnosing a condition of a central nervous system are provided. A method includes providing a DBSI-MRI data set obtained from the central nervous system of the subject, and transforming the DBSI-MRI data set to obtain at least one DBSI biomarker value. The method further includes comparing each DBSI biomarker value to at least one corresponding threshold value from a diagnostic database to obtain a relation between each DBSI biomarker value and the at least one corresponding threshold value, and diagnosing the condition according to at least one diagnostic rule, wherein each diagnostic rule defines a candidate condition in terms of the relations between the at least one DBSI biomarker value and the at least one corresponding threshold value.
    Type: Application
    Filed: April 28, 2017
    Publication date: May 23, 2019
    Applicant: Washington University
    Inventors: Yong Wang, Qing Wang, Tammie Benzinger
  • Publication number: 20190151471
    Abstract: The present application discloses a recombinant AAV vector comprising a promoter that targets gene expression to myofibroblast-like lineage of cells in the heart. The present application, also discloses the preparation and use of AAV expression cassettes using a modified periostin promoter that successfully drives gene expression in cardiac myofibroblast-like cells. The present invention encompasses compositions and methods useful for treating myocardial infarction. Further comprising compositions and methods for preparing and using AAV vectors for targeting cells and inducing gene expression. The compositions and methods of the invention are useful for efficiently targeting cardiac myofibroblasts following a cardiac injury, disease, or disorder. Further comprising a kit for effecting alleviation of the various diseases or disorders recited herein.
    Type: Application
    Filed: March 1, 2017
    Publication date: May 23, 2019
    Applicant: University of Virginia Patent Foundation
    Inventor: Brent A. French
  • Publication number: 20190151440
    Abstract: Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 23, 2019
    Applicants: Los Alamos National Security, LLC, Oxford University Innovation Limited
    Inventors: Bette T. M. Korber, Tomas Hanke, Andrew McMichael
  • Publication number: 20190153487
    Abstract: The present invention discloses synthetic fusion gene comprising hex1 and pox1 genes, their process of preparation, polypeptide(s) encoded by the same and its use thereof for biological pre-treatment of biomass for the production of biodiesel.
    Type: Application
    Filed: April 1, 2015
    Publication date: May 23, 2019
    Applicant: Universiti Brunei Darussalam
    Inventors: Prabitha VINODH KUMAR, Zohrah SULAIMAN
  • Publication number: 20190151147
    Abstract: An implantable device comprising a substrate capable of capturing an intraocular target molecule and to methods of use thereof. The substrate may be capable of capturing a target molecule present in the eye and/or from fluid of the eye (e.g., an intraocular target molecule). In some embodiments, the substrate has a relatively high affinity for a target molecule.
    Type: Application
    Filed: November 9, 2018
    Publication date: May 23, 2019
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventor: Jeffrey Olson
  • Publication number: 20190153082
    Abstract: Provided are novel specific binding molecules, particularly human antibodies as well as fragments, derivatives and variants thereof that recognize neoepitopes of disease-associated proteins which derive from native endogenous proteins but are prevalent in the body of a patient in a variant form and/or out of their normal physiological context. In addition, pharmaceutical compositions comprising such binding molecules, antibodies and mimics thereof and methods of screening for novel binding molecules, which may or may not be antibodies as well as targets in the treatment of neurological disorders such as Alzheimer's disease are described.
    Type: Application
    Filed: December 19, 2018
    Publication date: May 23, 2019
    Applicant: University of Zurich
    Inventors: Roger Nitsch, Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot, Jan Grimm
  • Publication number: 20190154683
    Abstract: Hierarchical films with structurally regulated functionalities through the integration of two-dimensional and three-dimensional structures to achieve ultra low nonspecific binding and high loading of molecular recognition elements, and methods for making and using the films.
    Type: Application
    Filed: July 23, 2018
    Publication date: May 23, 2019
    Applicant: University of Washington through its Center for Commercialization
    Inventors: Shaoyi Jiang, Norman David Brault, JR., Harihara S. Sundaram, Chun-Jen Huang, Qiuming Yu, Yuting Li
  • Publication number: 20190151371
    Abstract: The present invention is directed towards methods of culturing pancreatic islet cells, with the methods comprising culturing pancreatic islet cells in the presence a cell culture medium while inhibiting the activity of Rho kinase (ROCK) in the cells during culturing.
    Type: Application
    Filed: June 9, 2017
    Publication date: May 23, 2019
    Applicant: Georgetown University
    Inventors: Ian Gallicano, Samiksha Mahapatra